Variables | Total patients (n=22) |
---|---|
Peritoneal cancer index (PCI)* | |
<10 | 7 (31.8) |
10-19 | 11 (50.0) |
≥20 | 4 (18.2) |
Mean PCI† | 12.0 ± 7.9 (0-26) |
Median PCI ‡‡ | 13 (3-17) |
Completeness of cytoreduction (CC) | |
CC-0 | 22 (100) |
CC-1 | 0 |
Total operative time†, hour | 11.4 ± 2.6 (7.5-16.5) |
Operative time for concurrent liver surgery†, hour | 3.0 ± 2.5 (0.5-9.0) |
Estimated blood loss†, mL | 1418.6 ± 1204.1 (250-5000) |
Intraoperative transfusion†, mL | 475.4 ± 740.4 (0-3030) |
Postoperative laboratory findings‡ | |
CEA , ng/mL | 2.6 (0.4-32.9) |
CA 19-9 , U/mL | 29.4 (4.1-232) |
Hemoglobin , g/dL | 10.6 (7.5-13.7) |
Albumin , g/dL | 2.7 (1.4-3.3) |
Total bilirubin , mg/dL | 1.3 (0.4-2.4) |
AST , IU/L | 170.5 (77-498) |
ALT , IU/L | 137 (30-440) |
Length of ICU stay‡, days | 3.1 ± 7.9 (0-38) |
Length of hospital stay‡, days | 25.6 ± 16.7 (9-71) |
Numbers to treat adjuvant chemotherapy* | 21 (95.5) |
Interval between surgery and adjuvant chemotherapy‡‡, days | 40.5 (31-63) |